BUY. Well poised for strong growth RBL BANK. Target Price: Rs 650. Key highlights. Financial summary (Standalone) Y/E March FY17 FY18E FY19E FY20E

Transcription

1 4 APR 218 Visit Note BUY Target Price: Rs 65 Well poised for strong growth We met with the senior management of RBL and came back confident on its outlook and execution capabilities. Growth rates to remain healthy with benefits flowing from multi-channel distribution network. NIM to remain intact with granular retail franchise. Some near-term challenges persists like asset quality pain in farm loan book and credit costs linked to demon-impacted MFI loans, which will ease over next few quarters. We expect RBL to scale up materially without any significant teething issues while achieving best in class performance across major parameters. RBL is transitioning from being a wholesale-focused regional player to an agile technology-leader with a diversified portfolio, focus on strategic niche customer segments, and pan-india aspirations. Retain BUY with a TP of Rs 65. CMP : Rs 477 Potential Upside : 36% MARKET DATA No. of Shares : 42 mn Free Float : 1% Market Cap : Rs 2 bn 52-week High / Low : Rs 6 / Rs 443 Avg. Daily vol. (6mth) : 1.3 mn shares Bloomberg Code : RBK IB Equity Promoters Holding : % FII / DII : 38% / 12% Key highlights Credit cost guidance remains intact at 2-2.5% for FY18. GNPAs in the financial inclusion business is expected to be brought down to ~1% (5.2% in Q3FY18) after the accelerated provisions and write-offs in FY19 Loan growth is expected to remain strong at -35% going forward. Credit card business is expected to gain strong traction and will be a high ROA generating business Given the benefit from reduction in cost of funds and gradual change in loan mix in favour of retail, NIM is expected to be maintained ~3.9% Maintain BUY with TP of Rs 65 (3.4x FY2E ABV; upside 36% from CMP): RBL will command a premium to peers given (1) loan growth 3-4x of industry for foreseeable future, (2) ample scope of improving its low cost deposits and fee income, (3) negligible legacy issues, and (4) value accretion from significant rise in retail assets (tie-up with Bajaj Finance/new gen/e-comm players). We value RBL at 3.4x FY2E P/ABV to arrive at TP of Rs 65. At CMP of Rs 477, RBL trades at 2.5x FY2E P/ABV. Financial summary (Standalone) Y/E March FY17 FY18E FY19E FY2E PAT (Rs mn) 4,46 6,321 8,646 11,6 EPS (Rs) EPS chg Book value (Rs) Adj. BV (Rs) PE (x) P/ABV (x) RoE RoA Net NPA Key drivers Q1 18 Q2 18 Q3 18 YoY Loan growth NIM Cost-Income ratio GNPA ratio Price performance BANKEX RBL Bank, CMP as on 27th Mar Apr-17 Jul-17 Oct-17 Jan-18 1

2 Concerns over asset quality of microfinance business abating GNPA ratio in the financial inclusion business seemed to have peaked (5.2% in Q3FY18). RBL has already provided for 35% of the pain portfolio and the balance will be provided for in FY19. Post the accelerated provisioning and write-offs, GNPAs in this business is expected be brought down to ~1% by FY19 end Normalized credit cost in the microfinance business is ~5-7 bps. FY2 onwards the management aims to strengthen this portfolio by creating additional buffers for any unexpected events in the future RBL is not disbursing new microfinance loans in problematic areas but collection process is continuing with a recovery rate of ~25% Exhibit 1: Trend in asset quality GNPA NNPA PCR (RHS) Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 FY16 FY17 FY Management highlighted that 75% of the current microfinance portfolio has been disbursed post Jan'17 with low expected credit cost of ~ bps Overall credit costs guidance maintained at 2-2.5% GNPA ratio in the credit card business stood ~1.1% in Q3FY18 and is better than industry average of %. Management highlighted that asset quality of this business is getting better with improving origination quality and credit tested customers of BAF linked credit cards RBL's internally generated agri book stands at Rs 19 bn and has remained stagnant over past two years given the monsoon and political disturbances surrounding the sector. Some challenges may be visible in this book in near term Management is recalibrating its strategy about growing the agri book by doing selective product lending, but will remain watchful over next six months Exhibit 2: Trend in credit cost 4 (bps) Overall credit cost guidance for FY18 was maintained at 2-2.5% Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 FY16 FY17 FY18 2

3 Credit card business gaining strong traction Post the launch of co-branded credit card with Bajaj Finance (BAF), RBL is witnessing strong traction in this portfolio. BAF contributes nearly 5% to RBL's credit card base of ~.7 mn cards RBL aims to add nearly 1 mn cards in FY19 and intends to be the 3rd/4th largest card issuer in the country over the next 4-5 years ROA in this business is ~1%. Credit card is an upfront heavy investment business but over the next 3-4 years, this business is expected to generate ROA of 4-5% RBL cross sell like "loan on phone" to a credit card customer will lead to fee income for BAF and should increase substantially as volumes increase Management aims to ramp up BAF-linked credit card business significantly over the next few years and believes it will be a high ROE generating business given that it has limited sourcing costs, provided to existing credit tested customers and completely digital Exhibit 3: RBL has a diversified loan book 1% 8% 6% 4% 2% % C&IB CB BBB Agri DB&FI Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 FY16 FY17 FY18 Credit growth guidance maintained at -35% The bank largely follows a cross-sell model in growing the wholesale book and expects this book to grow by ~%. A large part of the growth is driven by the fact that public sector banks have vacated the space and pricing pressure is gradually easing off Management highlighted that RBL has business relations with 4-5% of India s top 1 groups in some form or the other. The bank has stayed away from generic infra loans and largely focused on shorter tenure like 2-3 years rather than 15 year loans in the infra space Management highlighted that RBL has business relations with 4-5% of India s top 1 groups in some form or the other The management highlighted that they are witnessing early signs of private sector capex picking up. Also, they are expecting refinancing opportunities in the next months related to resolutions of large stressed accounts The bank has tie-ups with 8 business correspondents for the microfinance and MSME business. Its subsidiary, Swadhaar FinServe originates 4% of the incremental microfinance business and contributes 35% to the portfolio. More so, it contributes a bulk of the MSME business 3

4 Exhibit 4: Management guides for -35% credit growth in longer run Advances YoY Growth (RHS) 8 (Rs bn) FY13 FY14 FY15 FY16 FY17 FY18E FY19E FY2E NIM expected to stay intact Cost of funds has come down for RBL over the past few quarters given reduction in market rates, progressive reduction in deposit rates as well as improvement in CASA ratio (24% in Q3FY18) This in part has aided NIM which has been consistently improving over the past few quarters. Management is hopeful of maintaining NIM at ~3.9% Exhibit 5: Margin (calc) to remain largely resilient at current level NIM (RHS) Yields on advances Cost of funds FY13 FY14 FY15 FY16 FY17 FY18E FY19E FY2E

5 Financial summary (Standalone) Profit & loss (Rs mn) Y/E March FY17 FY18E FY19E FY2E Interest earned 37,132 45,554 57,641 73,936 Interest expended (24,918) (28,76) (34,963) (45,611) Net interest income 12,213 17,478 22,678 28,325 Non interest income 7,555 1,51 13,744 16,955 Net income 19,768 27,979 36,422 45,28 Operating expenses (1,564) (14,834) (19,26) (23,112) Staff expenses (4,461) (5,713) (7,21) (9,137) Other operating expenses (6,12) (9,12) (11,825) (13,975) Operating profit 9,24 13,146 17,396 22,168 Provisions & contingencies (2,389) (3,569) (4,296) (4,592) Pre-tax profit 6,815 9,577 13,1 17,576 Tax expense (2,354) (3,256) (4,454) (5,976) Profit after tax 4,46 6,321 8,646 11,6 Extraordinary item Minority interest/associates Adj. PAT 4,46 6,321 8,646 11,6 Balance sheet (Rs mn) Y/E March FY17 FY18E FY19E FY2E Total assets 486, , , ,691 Cash & Balances with RBI 41,936 4,542 46,465 57,486 Investments 134, , ,963 23,469 Advances 294,49 397, , ,642 Fixed assets 2,587 2,393 2,137 1,812 Other assets 12,917 16,765 22,7 26,282 Total liabilities 486, ,42 763, ,691 Equity capital 3,752 4,18 4,18 4,18 Preference capital Reserves & surplus 39,594 61,58 68,981 79,114 Networth 43,346 65,688 73,161 83,294 Borrowings 79,798 87,777 94,96 15,781 Deposits 345, , , ,215 Other liabilities & prov. 17,713 2,947 26,465,391 Key ratios Y/E March FY17 FY18E FY19E FY2E Per share data FDEPS (Rs.) BV (Rs.) Adj. BV (Rs.) DPS (Rs.) Dividend payout Yields & Margins Yield on advances Cost of deposit Net interest margin Asset quality Gross NPAs Net NPAs Credit cost Provisioning coverage Capital Tier-I CAR Efficiency ROA ROE Cost to income CASA Effective tax rate Growth Net interest income Fee income Operating expenses Profit after tax Advances Deposits Total assets Note: Dividend for FY17 will be reflected in FY18 due to change in reporting method as per schedule 3 5

6 Disclosures: The following Disclosures are being made in compliance with the SEBI Research Analyst Regulations 214 (herein after referred to as the Regulations). 1. Axis Securities Ltd. (ASL) is a SEBI Registered Research Analyst having registration no. INH297. ASL, the Research Entity (RE) as defined in the Regulations, is engaged in the business of providing Stock broking services, Depository participant services & distribution of various financial products. ASL is a subsidiary company of Axis Bank Ltd. Axis Bank Ltd. is a listed public company and one of India s largest private sector bank and has its various subsidiaries engaged in businesses of Asset management, NBFC, Merchant Banking, Trusteeship, Venture Capital, Stock Broking, the details in respect of which are available on 2. ASL is registered with the Securities & Exchange Board of India (SEBI) for its stock broking & Depository participant business activities and with the Association of Mutual Funds of India (AMFI) for distribution of financial products and also registered with IRDA as a corporate agent for insurance business activity. 3. ASL has no material adverse disciplinary history as on the date of publication of this report. 4. I/We, authors (Research team) and the name/s subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect my/our views about the subject issuer(s) or securities. I/We also certify that no part of my/our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. I/we or my/our relative or ASL does not have any financial interest in the subject company. Also I/we or my/our relative or ASL or its Associates may have beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of the Research Report. Since associates of ASL are engaged in various financial service businesses, they might have financial interests or beneficial ownership in various companies including the subject company/companies mentioned in this report. I/we or my/our relative or ASL or its associates do not have any material conflict of interest. I/we have not served as director, officer or employee in the subject company. Research Team Sr. No Name Designation 1 Research Analyst siji.philip@axissecurities.in Research Analyst 2 Research Associate rohit.chawla@axissecurities.in Research Associate 5. ASL or its associates has not received any compensation from the subject company in the past twelve months. ASL or its Research Analysts has not been engaged in market making activity for the subject company. 6. In the last 12-month period ending on the last day of the month immediately preceding the date of publication of this research report, ASL or any of its associates may have: i. Received compensation for investment banking, merchant banking or stock broking services or for any other services from the subject company of this research report and / or; ii. Managed or co-managed public offering of the securities from the subject company of this research report and / or; iii. Received compensation for products or services other than investment banking, merchant banking or stock broking services from the subject company of this research report; ASL or any of its associates have not received compensation or other benefits from the subject company of this research report or any other third-party in connection with this report Term& Conditions: This report has been prepared by ASL and is meant for sole use by the recipient and not for circulation. The report and information contained herein is strictly confidential and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent of ASL. The report is based on the facts, figures and information that are considered true, correct, reliable and accurate. The intent of this report is not recommendatory in nature. The information is obtained from publicly available media or other sources believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. The report is prepared solely for informational purpose and does not constitute an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments for the clients. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. ASL will not treat recipients as customers by virtue of their receiving this report. 6

7 DEFINITION OF RATINGS Disclaimer: Ratings Expected absolute returns over months BUY More than 1% HOLD Between 1% and -1% SELL Less than -1% Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to the recipient s specific circumstances. The securities and strategies discussed and opinions expressed, if any, in this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient. This report may not be taken in substitution for the exercise of independent judgment by any recipient. Each recipient of this report should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this report (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. Certain transactions, including those involving futures, options and other derivatives as well as non-investment grade securities involve substantial risk and are not suitable for all investors. ASL, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on basis of this report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction in the dividend or income, etc. Past performance is not necessarily a guide to future performance. Investors are advise necessarily a guide to future performance. Investors are advised to see Risk Disclosure Document to understand the risks associated before investing in the securities markets. Actual results may differ materially from those set forth in projections. Forward-looking statements are not predictions and may be subject to change without notice. ASL and its affiliated companies, their directors and employees may; (a) from time to time, have long or short position(s) in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities or earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or investment banker, lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. Each of these entities functions as a separate, distinct and independent of each other. The recipient should take this into account before interpreting this document. ASL and / or its affiliates do and seek to do business including investment banking with companies covered in its research reports. As a result, the recipients of this report should be aware that ASL may have a potential conflict of interest that may affect the objectivity of this report. Compensation of Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. ASL may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. Neither this report nor any copy of it may be taken or transmitted into the United State (to U.S. Persons), Canada, or Japan or distributed, directly or indirectly, in the United States or Canada or distributed or redistributed in Japan or to any resident thereof. If this report is inadvertently sent or has reached any individual in such country, especially, USA, the same may be ignored and brought to the attention of the sender. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject ASL to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. The Disclosures of Interest Statement incorporated in this document is provided solely to enhance the transparency and should not be treated as endorsement of the views expressed in the report. The Company reserves the right to make modifications and alternations to this document as may be required from time to time without any prior notice. The views expressed are those of the analyst(s) and the Company may or may not subscribe to all the views expressed therein. Copyright in this document vests with Axis Securities Limited. Axis Securities Limited, SEBI Single Reg. No.- NSE, BSE & MSEI INZ161633, ARN No. 6461, CDSL-IN-DP-CDSL , SEBI-Research Analyst Reg. No. INH 297, SEBI Portfolio Manager Reg. No.- INP654, Main/Dealing off.- Unit No. 2, Phoenix Market City, 15, LBS Road, Near Kamani Junction, Kurla (west), Mumbai-47, Tel No , Reg. off.- Axis House, 8th Floor, Wadia International Centre, Pandurang Budhkar Marg, Worli, Mumbai 4 25.Compliance Officer: Anand Shaha, ID: compliance.officer@axisdirect.in,tel No: